Why Jounce Shares Are Crumbling Ahead of ASCO
Jounce Therapeutics watched its shares crumble on Thursday after the firm released data from its midstage cancer trial.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 135
Why Evolus Shares Are Getting Slammed
Evolus watched its shares come crashing down on Wednesday after the company announced that the FDA issued a Complete Response Letter for its treatment of glabellar lines, also known as frown lines, in adult…
Are Abaxis Shareholders Getting Enough in the Buyout?
Abaxis shares hit an all-time high early on Wednesday after it was announced that Zoetis would be acquiring the firm.
Are Xenon Pharmaceuticals Shares Making a Run?
Xenon Pharmaceuticals shares saw a handy gain on Tuesday after the firm announced positive data from a couple of its trials in the treatment of epilepsy.
UBS Makes Big Health Care Swap in Top Performing Q-GARP Portfolio
Managers of the UBS Q-GARP portfolio continue searching for high-quality U.S. growth companies that are trading at attractive valuations. They maintain that recent volatility in the market has had no impact on their process.
Can the Mayo Clinic Teach Trump Anger Management and Create a New Industry?
President Trump gets mad at many people and reportedly has a foul temper. The Mayo Clinic advises those who are plagued by the problem, and its expertise could open the door for an entirely…
Big Biotechs Scare Off Short Sellers
The April 30 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
Short Sellers Run for Cover From Major Pharma
The April 30 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
4 Specialty Pharma Stocks That Deutsche Bank Likes for the Rest of 2018
There is deep value for long-term investors in these specialty pharmaceutical companies, and the ability to buy in to some of the best companies in the industry at rock bottom pricing.
What Will Become of Valeant Pharmaceuticals?
Valeant Pharmaceuticals released its most recent quarterly report and announced a name change before the markets opened on Tuesday.
Are Athenahealth Shareholders Getting Enough in This Go-Private Offer?
Athenahealth shares are jumping on Monday after it was announced that Elliot Management wants to take the company private.
The Top Biopharma Catalysts Coming in May
Here 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and FDA updates in May.
Portola Pharmaceuticals Wins Big With FDA Approval
Portola Pharmaceuticals saw its shares soar on Friday after the firm announced that it had received an approval from the FDA.
Why Achaogen Shares Are Getting Crushed
As we have said before, the FDA has the potential to make or break biopharma companies, and in this case Achaogen is feeling the burn.
Is This the Turnaround Teva Has Been Waiting For?
Teva Pharmaceutical Industries released its most recent quarterly report before the markets opened on Thursday.